MedPath

Evaluation of the clinical utility of ultrasensitive C-peptide assay with glucagon stimulation test in Type 1 diabetic patients

Not Applicable
Conditions
Type 1 diabetes
Registration Number
JPRN-UMIN000010575
Lead Sponsor
juntendo university
Brief Summary

The number of registered cases was not sufficient. Analysis of patients who were able to perform the study showed no difference in residual endogenous insulin secretion depending on duration.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patients with serious liver or renal insufficiency (2)Patients with remarkable metabolic disorder (3)Judged as ineligible by clinical investigators

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Variability of glucose daily profile by using Continuous Glucose Monitoring System and Self Monitoring Blood Glucose
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath